Learn More

Chuzhou Qingyun Pharmaceutical Co., LTD

Provide high-quality active pharmaceutical ingredients and intermediates that comply with USP/EP/JP standards for global pharmaceutical enterprises.

Bestsellers

It is a comprehensive private high-tech enterprise specializing in the research, development, production and trade of pharmaceutical raw materials, intermediates and fine chemicals. The company was approved by the Anhui Provincial Administration for Industry and Commerce in August 2003 and is located at No. 25, Jinchuan Road, Shuangfeng Development Zone, Hefei City.

Z7-Z.jpg
N8-Z.jpg
SL-3-Z.jpg
RD-5-Z.jpg

4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-methanol

2-Cyclopropyl-4-(4-fluorophenyl)-3-Quinolinecarboxaldehyde

2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate

4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester

图片
图片
图片
图片

Our Advantages

图片
图片
图片
图片

Production capacity

Environmental protection leading

Hardcore technical support

Outstanding product advantages

The company covers an area of approximately 100 mu, with 2 professional workshops, equipped with 81 reaction vessels, 15 centrifuges and 11 drying devices. The total reaction volume reaches 224,600 liters. Additionally, there is a 4,110 square meter warehouse, with a daily sewage treatment capacity of 500 cubic meters.

We independently invested 3 million US dollars to upgrade the sewage treatment facilities and renovate the ventilation system in the workplace. We strictly implemented the EHS concept to achieve the coordinated development of production and environmental protection.

With profound technical reserves; It has applied for 50 invention patents, including 30 national patents and 4 US patents, covering the synthesis methods of key products such as rosuvastatin calcium and silodoxin. Its technological innovation capacity is leading in the industry.

For over a decade, we have been deeply engaged in the field of lipid-lowering drugs, specializing in the production of intermediates such as rosuvastatin calcium and pivastatin calcium. Our product quality complies with international standards such as USP, EP, JP, and CP, and we pass more than ten strict audits every year.

397f8668-d66c-49b0-af9c-af9a3e2c3aa6.gif

Your Source for Advanced Intermediates

We specialize in high-purity intermediates for Cardiovascular and CNS therapies, with deep expertise in complex reactions like hydrogenation and chiral synthesis. Our flagship products, including key intermediates for Rosuvastatin Calcium and Ranolazine, are trusted by clients in over a dozen countries for their consistent quality, meeting USP/EP/JP/CP standards.

Our pipeline, featuring Cariprazine and Pazopanib, is designed to support the future of medicine. We provide a stable supply chain and competitive solutions for the global generics market.


Elevate your supply chain.

QC工作图.jpg

Advanced Synthesis, Global Reach: Qingyun Pharma

Chuzhou Qingyun Pharmaceutical is a trusted manufacturer of advanced pharmaceutical ingredients and intermediates. Since 2016, our modern 100-acre facility in Anhui, China, has been built for scale and sustainability, featuring over 180 reactors and stringent environmental systems.

Driven by strong R&D with 30+ authorized patents and a firm commitment to EHS principles, we deliver quality and reliability. We successfully pass numerous international audits annually and are a proud partner to the world's leading generic drug companies. Our mission is to become the top global brand in specialty generics.


Ready to innovate together?

Learn More工厂大门照片1.jpg

Sold in More Than 20 Countries

Our products have gained trust across the globe, reaching over 10 countries like Japan, South Korea and India.

Company News
High-end pharmaceutical excipients: Strengthening the foundation and empowering preparations
High-end pharmaceutical excipients: Strengthening the foundation and empowering preparationsHigh-end pharmaceutical excipients also play an indispensable and crucial role in the modern pharmaceutical industry. It is by no means a simple auxiliary ingredient, but has a decisive influence on key properties such as the stability, solubility, r
Created on 09.02
Specialty active pharmaceutical ingredients: Innovation leads the way, quality first
Specialty active pharmaceutical ingredients: Innovation leads the way, quality firstSpecialty apis, as the backbone of the API field, are significantly different from traditional bulk apis. It focuses on drugs whose patents have not yet expired or those with special therapeutic needs. The research and development and manufacturing a
Created on 09.02
The supply chain reorganization of multinational pharmaceutical companies has brought favor to Chinese CDMO enterprises
The supply chain reorganization of multinational pharmaceutical companies has brought favor to Chinese CDMO enterprisesThe supply chains of multinational pharmaceutical companies are undergoing a profound reorganization. Chinese CDMO (Contract Development and Manufacturing Organization) enterprises, with their strong technical strength, cost-effectiveness and continu
Created on 09.02
As competition in the Indian market intensifies, Chinese enterprises are focusing on high-barrier intermediates to break through
As competition in the Indian market intensifies, Chinese enterprises are focusing on high-barrier intermediates to break throughFacing the price competition from India in the field of generic drug intermediates, Chinese enterprises have turned to high-tech barrier products in search of breakthroughs. For instance, Shengnuo Biotech focuses on GLP-1 weight loss drug intermediat
Created on 09.02
Our technological advantages
Our technological advantagesOur technological advantages Synthesis of chiral compounds, ultra-low temperature reactions, anhydrous and oxygen-free reactions, hydrogenation reactions, reduction alkylation, Friedel-alkyl/acyl reactions, substitution reactions Patents: 50 inventions
Created on 09.02
Information disclosure on conducting clean production audits
Information disclosure on conducting clean production auditsCompany profile and environmental protection status Chuzhou Qingyun Pharmaceutical Co., Ltd. is an enterprise specializing in the research and development, production and trade of active pharmaceutical ingredients and pharmaceutical intermediates. Th
Created on 09.02
The Ministry of Science and Technology has issued the Special Plan for Biotechnology Innovation during the 13th Five-Year Plan Period.
The Ministry of Science and Technology has issued the Special Plan for Biotechnology Innovation during the 13th Five-Year Plan Period.On May 10th, the official website of the Ministry of Science and Technology released a message. In accordance with the overall arrangements of the Outline of the 13th Five-Year Plan for National Economic and Social Development of the People's Republic
Created on 09.02
Introduction to Anhui Qingyun Pharmaceutical Co., LTD
Introduction to Anhui Qingyun Pharmaceutical Co., LTDChuzhou Qingyun Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing enterprise specializing in the research and development, production and trade of active pharmaceutical ingredients and pharmaceutical intermediates. The company was established
Created on 09.02

Leave your information and we will contact you.

eb3f1f93-c4a0-4b09-826c-c85e273e64ee.jpg

About us

Company Profile

Production environment

News Center

High-end pharmaceutical excipients

Characteristic active drugs

Our technological advantages

Anhui Qingyun Pharmaceutical Co., LTD.

Ms.Zhou  Manager

Phone:+86 18056004009

MMail:zhou@qingyunpharm.com

Phone
Mail